Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Beckers

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitroLeo J Hofland, Joost van der Hoek, Peter M van Koetsveld, et al.
European Journal of Endocrinology|August 25, 2012
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patientsLaurent Vroonen, Marie-Lise Jaffrain-Rea, Patrick Petrossians, et al.
American Journal of Human Genetics|February 24, 2022
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantismMartin Franke, Adrian F Daly, Leonor Palmeira, et al.
Endocrine-Related Cancer|December 17, 2015
GHRH excess and blockade in X-LAG syndromeAdrian F Daly, Philippe A Lysy, Céline Desfilles, et al.
AACE Clinical Case Reports|May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric SomatotropinomaSelveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.
European Journal of Endocrinology|September 26, 2007
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein geneLuciana A Naves, Adrian F Daly, Jean-François Vanbellinghen, et al.
Endocrine|November 27, 2015
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndromeLuciana A Naves, Adrian F Daly, Luiz Augusto Dias, et al.
Endocrine-Related Cancer|August 14, 2013
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutationsMarie-Lise Jaffrain-Rea, Sandra Rotondi, Annarita Turchi, et al.
Journal of Molecular Endocrinology|June 11, 2016
Characterization of GPR101 transcript structure and expression patternsGiampaolo Trivellin, Ivana Bjelobaba, Adrian F Daly, et al.
Endocrine-Related Cancer|June 27, 2009
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implicationsMarie-Lise Jaffrain-Rea, Mariolina Angelini, Donatella Gargano, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitroLeo J Hofland, Joost van der Hoek, Peter M van Koetsveld, et al.
European Journal of Endocrinology|August 25, 2012
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patientsLaurent Vroonen, Marie-Lise Jaffrain-Rea, Patrick Petrossians, et al.
American Journal of Human Genetics|February 24, 2022
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantismMartin Franke, Adrian F Daly, Leonor Palmeira, et al.
Endocrine-Related Cancer|December 17, 2015
GHRH excess and blockade in X-LAG syndromeAdrian F Daly, Philippe A Lysy, Céline Desfilles, et al.
AACE Clinical Case Reports|May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric SomatotropinomaSelveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.
European Journal of Endocrinology|September 26, 2007
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein geneLuciana A Naves, Adrian F Daly, Jean-François Vanbellinghen, et al.
Endocrine|November 27, 2015
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndromeLuciana A Naves, Adrian F Daly, Luiz Augusto Dias, et al.
Endocrine-Related Cancer|August 14, 2013
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutationsMarie-Lise Jaffrain-Rea, Sandra Rotondi, Annarita Turchi, et al.
Journal of Molecular Endocrinology|June 11, 2016
Characterization of GPR101 transcript structure and expression patternsGiampaolo Trivellin, Ivana Bjelobaba, Adrian F Daly, et al.
Endocrine-Related Cancer|June 27, 2009
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implicationsMarie-Lise Jaffrain-Rea, Mariolina Angelini, Donatella Gargano, et al.
Pageof 18